CCU:BCSCompania Cervecerias Unidas S.A. Analysis
Data as of 2026-06-12 - not real-time
$11.48
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
The stock is trading at $11.48, just shy of its 20‑day SMA of 11.48 and well below the 50‑day SMA of 11.66, indicating short‑term weakness. RSI sits at 50.1, suggesting neutral momentum, while the MACD line is below its signal, flagging a bearish bias. Volume has been on a decreasing trend, adding pressure to the price, and the beta of roughly 1.0 points to market‑aligned risk. Volatility over the past 30 days is high at 34.9%, and the price is testing a support level near 10.88 with resistance around 12.09, framing a modest upside of about 4% per the DCF model.
Fundamentally, CCU delivers a solid dividend yield of 3.18% with a payout ratio near 60%, and free cash flow remains positive, supporting dividend sustainability. The forward PE of 12.9 and a modest revenue growth of 0.2% paint a picture of a value‑oriented consumer defensive player, while the DCF fair value suggests the shares are slightly undervalued relative to current pricing.
Fundamentally, CCU delivers a solid dividend yield of 3.18% with a payout ratio near 60%, and free cash flow remains positive, supporting dividend sustainability. The forward PE of 12.9 and a modest revenue growth of 0.2% paint a picture of a value‑oriented consumer defensive player, while the DCF fair value suggests the shares are slightly undervalued relative to current pricing.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Price below short‑term moving averages
- Bearish MACD and decreasing volume
- Support level near 10.88 limiting downside
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Slight DCF upside of ~4%
- Attractive dividend yield with sustainable payout
- Value‑oriented fundamentals and stable earnings
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Consumer defensive positioning in South America
- Consistent cash flow supporting dividends
- Undervaluation relative to fair value and modest growth
Key Metrics & Analysis
Financial Health
Revenue Growth0.20%
Profit Margin3.89%
P/E Ratio17.1
ROE7.90%
ROA3.29%
Debt/Equity71.05
P/B Ratio0.0
Free Cash Flow$33.5B
Technical Analysis
TrendBearish
RSI50.1
Support$10.88
Resistance$12.09
MA 20$11.48
MA 50$11.66
MA 200$12.53
MACDBearish
VolumeDecreasing
Fear & Greed Index86.71
Valuation
Fair Value$2,378.93
Target Price$11.94
Upside/Downside4.02%
GradeUndervalued
TypeValue
Dividend Yield3.18%
Risk Assessment
Beta1.01
Volatility34.88%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.